openPR Logo
Press release

AI-Tailored Footwear: IAMBIC's New Approach to Custom-Fit Shoes

12-02-2024 07:12 PM CET | Fashion, Lifestyle, Trends

Press release from: Getnews

/ PR Agency: Brand Featured
AI-Tailored Footwear: IAMBIC's New Approach to Custom-Fit

How advanced technology is enabling shoe fit personalization with a new level of precision
Image: https://www.getnews.info/uploads/b933fdb82aac48fd4d6ec2b58f0132c2.jpg

IAMBIC MODEL T AI-tailored, made-to-fit shoe

Research shows that 60 to 70% of people wear shoes that do not fit properly (Buldt & Menz, 2018). This statistic isn't surprising, given that the footwear industry has historically relied on standardized sizing to serve billions of unique feet. Yet even when two people share identical measurements, they could need completely different shoes. These facts underscore the complexity of shoe fit design, which has left generations settling for poor fit and pain. AI-driven solutions, such as IAMBIC's custom-fit MODEL T shoe, may offer a data-driven approach to this challenge.

The Problem with Standard Shoes

"Most people have fairly unique foot shapes," explains Dr. Hylton Menz, one of the world's leading podiatry researchers. "Yet, the majority of shoes in stores are designed around a hypothetical average foot." Drawing from over three decades of research, Menz notes that this disconnect can lead to a cascade of issues-from immediate pain to long-term problems like bunions, hammer toes, and compromised knee and back health.

Advanced Technology for AI-Tailored Shoes

IAMBIC's approach combines advanced technology with detailed fit analysis for their custom-fit MODEL T shoe, named a TIME Best Invention. The bespoke fitting process begins with a smartphone-based foot scan where users capture three images of each foot. This analysis generates over 20 distinct measurements to create a detailed digital profile of each foot's unique characteristics. Traditional sizing systems-even with extended sizing options and wide or narrow widths-still rely on standard length and width measurements, failing to capture the true complexity of foot shape.

Precision-Fit Beyond Foot Shape

Even when two people share identical measurements, their optimal footwear needs can differ significantly. The MODEL T's customization process acknowledges this complexity by considering more than just physical dimensions. Beyond the smartphone-based foot scan, users share their comfort preferences and lifestyle details. This data-whether someone prefers a snug or loose fit, more or less cushioning-are crucial because comfort is highly subjective and even millimeter differences can significantly impact fit satisfaction.

Foot Health

This customization system aims to create shoes with optimal fit and comfort for each individual. "IAMBIC's technology is a genuine game-changer," says Menz, explaining how the system "can actually look at the individual, work out the shape of their foot, work out what sort of footwear they need." The potential impact extends beyond individual comfort, as Menz notes: "This has a huge impact on foot health at the population level."

The Verdict

The MODEL T demonstrates how AI-driven analysis can advance footwear customization, addressing longstanding fit challenges that affect both comfort and foot health. Combining precise measurements with comfort preferences creates new possibilities in footwear fitting-transcends traditional sizing and widths to enable comprehensive fit personalization.

More information on custom-fit footwear is available at www.iambic.co [http://www.iambic.co/].

Image: https://www.getnews.info/uploads/f4e3161909870bb58597a937693c8cdb.jpg
Media Contact
Company Name: IAMBIC
Contact Person: Maeve Wang
Email: Send Email [http://www.universalpressrelease.com/?pr=aitailored-footwear-iambics-new-approach-to-customfit-shoes]
Phone: (631) 971-8642
Country: United States
Website: http://www.iambic.co



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release AI-Tailored Footwear: IAMBIC's New Approach to Custom-Fit Shoes here

News-ID: 3767009 • Views:

More Releases from Getnews

Ozark-Based Financial Firm Rebrands as Ozarks Retirement Group
Ozark-Based Financial Firm Rebrands as Ozarks Retirement Group
Trinity Insurance & Financial Services Inc., a leading financial planning firm with hundreds of millions of dollars under management, announced today it will officially rebrand as Ozarks Retirement Group LLC effective September 1, 2025. Founded in 2008, the firm has established itself as a trusted partner in retirement financial planning, serving more than 1,500 clients and managing over $400 million in assets. The rebrand reflects the firm's dedication to helping individuals
Stuart Curry Dentistry Provides Preventive Care Services in Birmingham to Improve Community Oral Health
Stuart Curry Dentistry Provides Preventive Care Services in Birmingham to Improv …
Image: https://www.globalnewslines.com/uploads/2025/01/1738071949.jpg Stuart Curry Dentistry is turning dental visits into a reason to grin, delivering top-notch preventive care that leaves Birmingham residents feeling confident and refreshed. Stuart Curry Dentistry is turning dental visits into a reason to grin, delivering top-notch preventive care that leaves Birmingham residents feeling confident and refreshed. Offering comprehensive Dental Checkups in Birmingham [https://www.barchart.com/story/news/32975086/healthy-teeth-healthy-life-visit-stuart-curry-dentistry-in-birmingham-al-for-comprehensive-dental-cleanings], the practice makes oral health a breeze for patients of all ages, from first-timers to
Shifton Announces Release of a Buyer's Guide to Modern WFM Platforms
Shifton Announces Release of a Buyer's Guide to Modern WFM Platforms
New guide helps organizations evaluate workforce management software with practical criteria for unified workforce operations SaaS, labor management, and payroll integration. Image: https://www.globalnewslines.com/uploads/2025/09/c832fa9868dee76cc7fa45a75ecffc0b.jpg Shifton [https://shifton.com?utm_source=pressrelease&utm_medium=referral&utm_campaign=buyersguide] today announced the release of a new buyer's guide designed to help organizations evaluate workforce management (WFM) solutions in a crowded and fragmented software market. The Shifton buyer's guide [https://shifton.com/blog/modern-wfm-platforms-buyers-guide/?utm_source=brandpush&utm_medium=pr&utm_campaign=wfm_short_guide_2025&utm_content=primary], available on the company's website, highlights the core structural features businesses should prioritize when selecting a modern
Environment Saver Plastic Pyrolysis Facility Accepts Initial Feedstock Ahead of Q4 Commissioning to Aid Global Plastic Crisis & Deliver Significant Job Creation: Clean Vision, Inc. (Stock Symbol: CLNV
Environment Saver Plastic Pyrolysis Facility Accepts Initial Feedstock Ahead of …
Image: https://www.globalnewslines.com/uploads/2025/09/1757507774.jpg $CLNV is a Technology Innovation Leader in Plastic Conversion and Circular Oil Development * Emerging Leader in Plastic Conversion and Circular Oil Development Projects. * Working Towards Efficient, Cost-Effective Technology Solutions to Address the Global Plastic Crisis, Creating Economic Opportunity and Social Benefits. * Clean-Seas Pyrolysis Deployment with Strategic Alliances for Plastic Diversion and Conversion, Including Plastic Feedstock and Off-Take Agreements. * Clean Vision Subsidiary

All 5 Releases


More Releases for IAMBIC

HER2+ Gastric Cancer Market Surges as Recent FDA Approvals and Late-Stage Clinic …
The HER2+ Gastric Cancer market is projected to grow significantly, attributed to several factors, including the increasing incidence and innovations in the treatment landscape by various HER2+ Gastric Cancer companies such as Roche, Elevar Therapeutic, BMS, Merck, Daiichi Sankyo, Genentech, Bayer, Loxo Oncology, Eli Lilly, Remegen, AstraZeneca, Hutchison Medipharma, LintonPharm, Qilu Pharmaceutical, Shanghai Henlius Biotech, Seagen, MacroGenics, Merus, OncXerna, Innovent Biologics, and others. DelveInsight's latest report, " [https://www.delveinsight.com/report-store/her2-positive-gastric-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]", provides an in-depth
Her2+ Non Small Cell Lung Cancer Market: Epidemiology, Therapies, Companies, Del …
Her2+ Non Small Cell Lung Cancer therapies, such as Pyrotinib, DZD9008, Mobocertinib (TAK-788), and others, are expected to boost the Her2+ Non Small Cell Lung Cancer Market in the upcoming years. DelveInsight has launched a new report on "Her2+ Non Small Cell Lung Cancer - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Her2+ Non Small Cell Lung Cancer, historical and forecasted epidemiology as well as
HER2+ Gastric Cancer Market to Witness Upsurge in Growth During the Forecast Per …
Key HER2+ Gastric Cancer companies in the market include - Roche, Elevar Therapeutic, Bristol-Myers Squibb, Merck, Daiichi Sankyo Inc., Genentech, Bayer/Loxo Oncology, Eli Lilly and Company, Remegen Biosciences, AstraZeneca, Hutchison Medipharma Limited, Jiangsu Alphamab Biopharmaceuticals, MacroGenics/Zai Lab, Merck Sharp & Dohme Corp., Merus N.V., OncXerna Therapeutics, Inc., Innovent Biologics, and others. The HER2+ Gastric Cancer market is projected to grow significantly in the 7MM, which includes the United States, EU4-Germany, France,